Humboldt Fund
Status
ACTIVE
Global HQ
United States
Countries of investment
- USA
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- AI
- Health Tech
- Biotechnology
About
Humboldt is a venture capital fund that invests in innovative, early-stage biotech enterprises, focusing on synthetic biology to revolutionize the production of chemicals, materials, foods, and medicines while addressing critical global challenges.
Humboldt is a venture capital fund that invests in innovative, early-stage biotech enterprises, focusing on synthetic biology to revolutionize the production of chemicals, materials, foods, and medicines while addressing critical global challenges.
Investment Thesis
They Focuses on early stage investments in technology and healthcare companies that are positioned for significant growth.
Manager's Experience
Boasting over a decade of experience in private equity and venture capital, the fund manager has successfully navigated multiple sectors, including technology and healthcare, while predominantly targeting North American markets. With a portfolio encompassing more than 30 investments, they emphasize a data-driven strategy that prioritizes operator-first approaches. The manager has achieved notable exits through strategic partnerships and innovative market positioning. Their focus on early to growth-stage investments underscores a commitment to fostering scalable business models with significant potential.
Humboldt Fund Contacts Information
Primary contact
Team
Sebastian Bernales